Royalty Pharma (RPRX) Earnings Date, Estimates & Call Transcripts → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free RPRX Stock Alerts $27.27 -0.61 (-2.19%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 9) $0.98 Beat By $0.02 Consensus EPS (May. 9) $0.96 Read Call TranscriptListen to Call Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRPRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RPRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. Royalty Pharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$4.03 EPSNext Year EPS Consensus Estimate: $4.40 EPSRPRX Earnings Date and InformationRoyalty Pharma last announced its earnings data on May 9th, 2024. The biopharmaceutical company reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.96 by $0.02. The company earned $568 million during the quarter, compared to analysts' expectations of $671.45 million. Royalty Pharma has generated $1.34 earnings per share over the last year ($1.34 diluted earnings per share) and currently has a price-to-earnings ratio of 20.4. Earnings for Royalty Pharma are expected to grow by 9.18% in the coming year, from $4.03 to $4.40 per share. Royalty Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Royalty Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024Estimated)------- 5/9/2024Q1 2024$0.96$0.98+$0.02$1.95$671.45 million$568.00 million 2/15/2024Q4 2023$1.03$1.15+$0.12$1.47$702.90 million$736.00 million11/8/2023Q3 2023$0.81$0.79($0.02)$1.46$640.96 million$637.00 million8/8/2023Q2 2023$0.83$0.85+$0.02$1.32$538.52 million$545.00 million5/9/2023Q1 2023$1.32$1.60+$0.28$2.64$914.72 million$1.13 billion2/15/2023Q4 2022$1.56$1.56-$3.87$1.06 billion$1.06 billionThe Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now.11/8/2022Q3 2022$0.71$0.73+$0.02$1.22$578.03 million$597.00 million8/4/2022Q2 2022$0.78$0.79+$0.01$1.08$511.87 million$524.00 million5/5/2022Q1 2022$0.72$0.61($0.11)$1.13$583.77 million$605.00 million2/15/2022Q4 2021$0.79$0.80+$0.01$1.59$543.50 million$543.00 million 11/10/2021Q3 2021$0.69$0.17($0.52)$1.29$568.92 million$587.00 million 8/11/2021Q2 2021$0.70$0.71+$0.01$0.69$474.52 million$475.00 million Royalty Pharma Earnings - Frequently Asked Questions When is Royalty Pharma's earnings date? Royalty Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on RPRX's earnings history. Did Royalty Pharma beat their earnings estimates last quarter? In the previous quarter, Royalty Pharma (NASDAQ:RPRX) reported $0.98 earnings per share (EPS) to beat the analysts' consensus estimate of $0.96 by $0.02. Learn more on analysts' earnings estimate vs. RPRX's actual earnings. How can I listen to Royalty Pharma's earnings conference call? The conference call for Royalty Pharma's latest earnings report can be listened to online. Listen to Conference Call How can I read Royalty Pharma's conference call transcript? The conference call transcript for Royalty Pharma's latest earnings report can be read online. Read Transcript How much revenue does Royalty Pharma generate each year? Royalty Pharma (NASDAQ:RPRX) has a recorded annual revenue of $2.24 billion. How much profit does Royalty Pharma generate each year? Royalty Pharma (NASDAQ:RPRX) has a recorded net income of $1.13 billion. RPRX has generated $1.34 earnings per share over the last four quarters. What is Royalty Pharma's price-to-earnings ratio? Royalty Pharma (NASDAQ:RPRX) has a trailing price-to-earnings ratio of 20.35 and a forward price-to-earnings ratio of 6.77. The price/earnings-to-growth ratio is 4.45. What is Royalty Pharma's EPS forecast for next year? Royalty Pharma's earnings are expected to grow from $4.03 per share to $4.40 per share in the next year, which is a 9.18% increase. More Earnings Resources from MarketBeat Related Companies: CFG Earnings Date EG Earnings Date L Earnings Date NMR Earnings Date MAA Earnings Date NTRS Earnings Date BAM Earnings Date HOOD Earnings Date AEG Earnings Date SHG Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (NASDAQ:RPRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist My Default Watchlist Adding Royalty Pharma plc You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
